SK Biopharmaceuticals builds 7 million-entry AI dataset for drug discovery
AI Summary- SK Biopharmaceuticals built an AI dataset containing more than 7 million chemical entries.
- The dataset covers 66 drug-development tasks, including toxicity and clinical-trial outcome prediction.
- SK Biopharmaceuticals plans to expand its TR-AX research strategy using Nvidia B200 infrastructure.